Bioactive agent release coating
First Claim
1. A composition for coating the surface of a medical device with one or more bioactive agents in a manner that permits the coated surface to release the bioactive agent(s) over time when implanted in vivo, the composition comprising one or more bioactive agents in combination with a first polymer component comprising at least one poly(alkyl)(meth)acrylate and a second polymer component comprising poly(ethylene-co-vinyl acetate), wherein the device is one that undergoes flexion and/or expansion in the course of implantation or use in vivo.
1 Assignment
0 Petitions
Accused Products
Abstract
A coating composition for use in coating implantable medical devices to improve their ability to release bioactive agents in vivo. The coating composition is particularly adapted for use with devices that undergo significant flexion and/or expansion in the course of their delivery and/or use, such as stents and catheters. The composition includes the bioactive agent in combination with a mixture of a first polymer component such as poly(butyl methacrylate) and a second polymer component such as poly(ethylene-co-vinyl acetate).
347 Citations
27 Claims
- 1. A composition for coating the surface of a medical device with one or more bioactive agents in a manner that permits the coated surface to release the bioactive agent(s) over time when implanted in vivo, the composition comprising one or more bioactive agents in combination with a first polymer component comprising at least one poly(alkyl)(meth)acrylate and a second polymer component comprising poly(ethylene-co-vinyl acetate), wherein the device is one that undergoes flexion and/or expansion in the course of implantation or use in vivo.
-
2. A composition for coating the surface of a medical device with one or more bioactive agents in a manner that permits the coated surface to release the bioactive agent(s) over time when implanted in vivo, the composition comprising one or more bioactive agents in combination with a first polymer component comprising at least one poly(alkyl)(meth)acrylate and a second polymer component comprising poly(ethylene-co-vinyl acetate), wherein the composition permits the amount and rate of release of agent(s) from the medical device to be controlled by adjusting the relative types and/or concentrations of polymers in the mixture.
-
3. A composition for coating the surface of a medical device with one or more bioactive agent(s) in a manner that permits the coated surface to release the bioactive agent(s) over time when implanted in vivo, the composition comprising one or more bioactive agent(s) in combination with a first polymer component comprising at least one poly(alkyl)(meth)acrylate and a second polymer component comprising poly(ethylene-co-vinyl acetate), wherein the device is selected from the group consisting of catheters and stents.
- 7. A polymeric coating composition comprising a first polymer component comprising at least one poly(alkyl)(meth)acrylate and a second polymer component comprising poly(ethylene-co-vinyl acetate) and one or more bioactive agents and positioned upon the surface of a medical device in a manner that permits the coated surface to release the bioactive agent(s) over time when implanted in vivo, wherein the composition provides sufficient durability and flexibility to be used upon a device is one that undergoes flexion and/or expansion in the course of implantation or use in vivo.
- 10. A method for providing an implantable medical device with a therapeutic effect, the method comprising the step of providing a medical device having a surface coated with a composition comprising one or more bioactive agents in a manner that permits the coated surface to release the bioactive agent(s) over time when implanted in vivo, the composition comprising one or more bioactive agents in combination with a first polymer component comprising at least one poly(alkyl)(meth)acrylate and a second polymer component comprising poly(ethylene-co-vinyl acetate), wherein the device is one that undergoes flexion and/or expansion in the course of implantation or use in vivo.
-
11. A method for providing an implantable medical device with a therapeutic effect, the method comprising the step of providing a medical device having a surface of the medical device with a composition comprising one or more bioactive agents in a manner that permits the coated surface to release the bioactive agent(s) over time when implanted in vivo, the composition comprising one or more bioactive agents in combination with a first polymer component comprising at least one poly(alkyl)(meth)acrylate and a second polymer component comprising poly(ethylene-co-vinyl acetate), wherein the composition permits the amount and rate of release of agent(s) from the medical device to be controlled by adjusting the relative types and/or concentrations of polymers in the mixture.
-
12. A method for providing an implantable medical device with a therapeutic effect, the method comprising the step of providing a medical device having a coated with a composition comprising one or more bioactive agent(s) in a manner that permits the coated surface to release the bioactive agent(s) over time when implanted in vivo, the composition comprising one or more bioactive agent(s) in combination with a first polymer component comprising at least one poly(alkyl)(meth)acrylate and a second polymer component comprising poly(ethylene-co-vinyl acetate), wherein the device is selected from the group consisting of catheters and stents.
- 16. A composition for coating the surface of a medical device with a bioactive agent in a manner that permits the coated surface to release the bioactive agent over time when implanted in vivo, the composition comprising a bioactive agent in combination with a plurality of polymers, including a first polymer component comprising at least one poly(alkyl)(meth)acrylate and a second polymer component comprising poly(ethylene-co-vinyl acetate).
Specification